Refine
Document Type
- Article (7)
Has Fulltext
- yes (7)
Is part of the Bibliography
- no (7)
Keywords
- Coleoptera (2)
- ADHD (1)
- Acylophorus wagenschieberi (1)
- Adventivart (1)
- Arteninventar (1)
- Autokeschers (1)
- BBB (1)
- Bestandeserfassung (1)
- Brain metastasis (1)
- Breast cancer (1)
Institute
- Medizin (2)
Am Kaiserstuhl bei Freiburg in Südwestdeutschland fand ich im Oktober 1999 die hauptsächlich asiatisch verbreitete Epuraea ocularis FAIRMAIRE; es ist die erste Meldung dieser Art aus Deutschland. Die ähnliche pantropische Art E. luteola ERICHSON breitet sich ebenfalls in Südeuropa aus und könnte auch nach Deutschland vordringen. Zur Identifizierung von E. ocularis und E. luteola wird die Bestimmungstabelle der mitteleuropäischen Epuraea-Arten (SPORNRAFT 1963) ergänzt.
Im Sommer 2001 wurden käferkundliche Exkursionen in verschiedenen Regionen Mitteleuropas sowie des angrenzenden Südostens durchgeführt. Ausser zahlreichen Neu- und Wiederfunden für die jeweilige Region gelang mit Pseudolathra manueli (Staphylinidae, Paederinae) auch ein Neufund für Deutschland. Im östlichen Ungarn wurde mehrfach eine noch nicht beschriebene Staphyliniden-Art der Gattung Atheta (U.G.Parameotica) gefunden.
In den Jahren 2003-2006 wurden im westlichen Polen im Bezirk Gorzow WLKP - hauptsächlich in der Umgebung von Skwierzyna - insgesamt über 1100 Käferarten nachgewiesen. Neben den üblichen Handfängen kam auch die Autokescher-Methode (= AK) zum Einsatz. In der ersten Tabelle werden die kompletten Funddaten von 190 aus Polen nur wenig oder noch nicht gemeldeten Arten mitgeteilt. Die Anhangtabelle enthält die übrigen Arten, aber ohne genaue Fundangaben. Diese sind jedoch bei Bedarf beim Erstautor abrufbar.
Attention-deficit/hyperactivity disorder (ADHD) is a common, highly heritable neurodevelopmental disorder. Genetic loci have not yet been identified by genome-wide association studies. Rare copy number variations (CNVs), such as chromosomal deletions or duplications, have been implicated in ADHD and other neurodevelopmental disorders. To identify rare (frequency ≤1%) CNVs that increase the risk of ADHD, we performed a whole-genome CNV analysis based on 489 young ADHD patients and 1285 adult population-based controls and identified one significantly associated CNV region. In tests for a global burden of large (>500 kb) rare CNVs, we observed a nonsignificant (P=0.271) 1.126-fold enriched rate of subjects carrying at least one such CNV in the group of ADHD cases. Locus-specific tests of association were used to assess if there were more rare CNVs in cases compared with controls. Detected CNVs, which were significantly enriched in the ADHD group, were validated by quantitative (q)PCR. Findings were replicated in an independent sample of 386 young patients with ADHD and 781 young population-based healthy controls. We identified rare CNVs within the parkinson protein 2 gene (PARK2) with a significantly higher prevalence in ADHD patients than in controls (P=2.8 × 10(-4) after empirical correction for genome-wide testing). In total, the PARK2 locus (chr 6: 162 659 756-162 767 019) harboured three deletions and nine duplications in the ADHD patients and two deletions and two duplications in the controls. By qPCR analysis, we validated 11 of the 12 CNVs in ADHD patients (P=1.2 × 10(-3) after empirical correction for genome-wide testing). In the replication sample, CNVs at the PARK2 locus were found in four additional ADHD patients and one additional control (P=4.3 × 10(-2)). Our results suggest that copy number variants at the PARK2 locus contribute to the genetic susceptibility of ADHD. Mutations and CNVs in PARK2 are known to be associated with Parkinson disease.
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases
(2019)
Background: Breast cancer (BC) is the most frequent malignant tumor in females and the 2nd most common cause of brain metastasis (BM), that are associated with a fatal prognosis. The increasing incidence from 10% up to 40% is due to more effective treatments of extracerebral sites with improved prognosis and increasing use of MRI in diagnostics. A frequently administered, potent chemotherapeutic group of drugs for BC treatment are taxanes usually used in the adjuvant and metastatic setting, which, however, have been suspected to be associated with a higher incidence of BM. The aim of our study was to experimentally analyze the impact of the taxane docetaxel (DTX) on brain metastasis formation, and to elucidate the underlying molecular mechanism.
Methods: A monocentric patient cohort was analyzed to determine the association of taxane treatment and BM formation. To identify the specific impact of DTX, a murine brain metastatic model upon intracardial injection of breast cancer cells was conducted. To approach the functional mechanism, dynamic contrast-enhanced MRI and electron microscopy of mice as well as in-vitro transendothelial electrical resistance (TEER) and tracer permeability assays using brain endothelial cells (EC) were carried out. PCR-based, immunohistochemical and immunoblotting analyses with additional RNA sequencing of murine and human ECs were performed to explore the molecular mechanisms by DTX treatment.
Results: Taxane treatment was associated with an increased rate of BM formation in the patient cohort and the murine metastatic model. Functional studies did not show unequivocal alterations of blood-brain barrier properties upon DTX treatment in-vivo, but in-vitro assays revealed a temporary DTX-related barrier disruption. We found disturbance of tubulin structure and upregulation of tight junction marker claudin-5 in ECs. Furthermore, upregulation of several members of the tubulin family and downregulation of tetraspanin-2 in both, murine and human ECs, was induced.
Conclusion: In summary, a higher incidence of BM was associated with prior taxane treatment in both a patient cohort and a murine mouse model. We could identify tubulin family members and tetraspanin-2 as potential contributors for the destabilization of the blood-brain barrier. Further analyses are needed to decipher the exact role of those alterations on tumor metastatic processes in the brain.
